Serum Proteomic Analysis of Peripartum Cardiomyopathy Reveals Distinctive Dysregulation of Inflammatory and Cholesterol Metabolism Pathways
JACC: Heart Failure · 2023
DOI: 10.1016/j.jchf.2023.05.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Heart Failure, 2023. Verfasst von Jana P Lovell und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Heart Failure, Cardiomyopathies, Puerperal Disorders, Pregnancy Complications, Cardiovascular. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, American Heart Association Inc, NIH Library.
Abstract (Originalsprache)
BACKGROUND: The pathophysiology of peripartum cardiomyopathy (PPCM) and its distinctive biological features remain incompletely understood. High-throughput serum proteomic profiling, a powerful tool to gain insights into the pathophysiology of diseases at a systems biology level, has never been used to investigate PPCM relative to nonischemic cardiomyopathy. OBJECTIVES: The aim of this study was to characterize the pathophysiology of PPCM through serum proteomic analysis. METHODS: Aptamer-based proteomic analysis (SomaScan 7K) was performed on serum samples from women with PPCM (n = 67), women with nonischemic nonperipartum cardiomyopathy (NPCM) (n = 31), and age-matched healthy peripartum and nonperipartum women (n = 10 each). Serum samples were obtained from the IPAC (Investigation of Pregnancy-Associated Cardiomyopathy) and IMAC2 (Intervention in Myocarditis and Acute Cardiomyopathy) studies. RESULTS: Principal component analysis revealed unique clustering of each patient group (P for difference
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Genetics, McDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
- Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins School of Medicine, Bal…
- Intermountain Heart Institute, Murray, Utah, USA.
- Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Förderung
- NHLBI NIH HHS
- American Heart Association Inc
- NIH Library
Zitieren
APA
Lovell, J. P., Bermea, K., Yu, J., Rousseau, S., Cohen, C. D., Bhalodia, A., Zita, M. D., Head, R. D., Blumenthal, R. S., Alharethi, R., Damp, J., Boehmer, J., Alexis, J., McNamara, D. M., Sharma, G., Adamo, L., IPAC, & IMAC2 Investigators (2023). Serum Proteomic Analysis of Peripartum Cardiomyopathy Reveals Distinctive Dysregulation of Inflammatory and Cholesterol Metabolism Pathways. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2023.05.031
Vancouver
Lovell JP, Bermea K, Yu J, Rousseau S, Cohen CD, Bhalodia A, et al. Serum Proteomic Analysis of Peripartum Cardiomyopathy Reveals Distinctive Dysregulation of Inflammatory and Cholesterol Metabolism Pathways. JACC: Heart Failure. 2023. doi:10.1016/j.jchf.2023.05.031
BibTeX
@article{Lovell2023,
author = {Lovell, Jana P and Bermea, Kevin and Yu, Jinsheng and Rousseau, Sylvie and Cohen, Charles D and Bhalodia, Aashik and Zita, Marcelle Dina and Head, Richard D and Blumenthal, Roger S and Alharethi, Rami and Damp, Julie and Boehmer, John and Alexis, Jeffrey and McNamara, Dennis M and Sharma, Garima and Adamo, Luigi and IPAC, IPAC and IMAC2 Investigators, IMAC2 Investigators},
title = {Serum Proteomic Analysis of Peripartum Cardiomyopathy Reveals Distinctive Dysregulation of Inflammatory and Cholesterol Metabolism Pathways},
journal = {JACC: Heart Failure},
year = {2023},
doi = {10.1016/j.jchf.2023.05.031}
}
EUVIMED